Bogart Wealth’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
Other funds holding CTKB
Bogart Wealth's CTKB Position: Q3 2023 in Review
Bogart Wealth sold out of Cytek Biosciences (CTKB) in Q3 2023, closing a stake of 24 shares — an estimated $205 sold.
Bogart Wealth first reported a position in CTKB in Q1 2023 and held it in 2 quarters. The position peaked at $221 in Q1 2023. 106 funds tracked by Wall St. Rank hold CTKB as of Q3 2023.
- Bogart Wealth reported no remaining Cytek Biosciences position as of Q3 2023 after selling out during the quarter.
- Bogart Wealth sold 24 Cytek Biosciences shares in Q3 2023, an estimated $205.
- Bogart Wealth first reported a position in Cytek Biosciences in Q1 2023 and held it in 2 quarters.
- Bogart Wealth's Cytek Biosciences position peaked at $221 in Q1 2023.
- 106 funds tracked by Wall St. Rank held Cytek Biosciences as of Q3 2023.
Based on Bogart Wealth's 13F filing for Q3 2023, filed 30 Oct 2023.